Sale by Elena Ridloff
3,000 shares · @ $87.00 · $261,000
Kymera Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $78.47
-4.1% in 7d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
+0.5%
7d
-4.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS